nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Acamprosate—Discomfort—Triamcinolone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Acamprosate—Discomfort—Methylprednisolone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Acamprosate—Dry mouth—Triamcinolone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Acamprosate—Angioedema—Dexamethasone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Acamprosate—Angioedema—Betamethasone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Acamprosate—Stomatitis—Methotrexate—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Acamprosate—Confusional state—Methylprednisolone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Acamprosate—Immune system disorder—Prednisone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Acamprosate—Malaise—Dexamethasone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Acamprosate—Malaise—Betamethasone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Acamprosate—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Acamprosate—Vertigo—Dexamethasone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Acamprosate—Vertigo—Betamethasone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Acamprosate—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Acamprosate—Syncope—Dexamethasone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Acamprosate—Syncope—Betamethasone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Acamprosate—Infection—Triamcinolone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Acamprosate—Sweating—Methotrexate—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Acamprosate—Infection—Methylprednisolone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Acamprosate—Haematuria—Methotrexate—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Acamprosate—Shock—Triamcinolone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Acamprosate—Insomnia—Prednisolone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Acamprosate—Alopecia—Prednisone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Acamprosate—Shock—Methylprednisolone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Acamprosate—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Acamprosate—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Acamprosate—Epistaxis—Methotrexate—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Acamprosate—Paraesthesia—Prednisolone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Acamprosate—Tachycardia—Triamcinolone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Acamprosate—Mental disorder—Prednisone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Acamprosate—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Acamprosate—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Acamprosate—Malnutrition—Prednisone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Acamprosate—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Acamprosate—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Acamprosate—Convulsion—Dexamethasone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Acamprosate—Convulsion—Betamethasone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Acamprosate—Hypertension—Betamethasone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Acamprosate—Hypertension—Dexamethasone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Acamprosate—Myalgia—Dexamethasone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Acamprosate—Myalgia—Betamethasone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Acamprosate—Anxiety—Dexamethasone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Acamprosate—Anxiety—Betamethasone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Acamprosate—Discomfort—Dexamethasone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Acamprosate—Discomfort—Betamethasone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Acamprosate—Haemoglobin—Methotrexate—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Acamprosate—Hypotension—Methylprednisolone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Acamprosate—Pain—Prednisolone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Acamprosate—Haemorrhage—Methotrexate—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Acamprosate—Hepatitis—Methotrexate—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Acamprosate—Pharyngitis—Methotrexate—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Acamprosate—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Acamprosate—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Acamprosate—Insomnia—Triamcinolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Acamprosate—Insomnia—Methylprednisolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Acamprosate—Infection—Dexamethasone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Acamprosate—Infection—Betamethasone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Acamprosate—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Acamprosate—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Acamprosate—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Acamprosate—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Acamprosate—Visual impairment—Methotrexate—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Acamprosate—Anaemia—Prednisone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Acamprosate—Shock—Dexamethasone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Acamprosate—Shock—Betamethasone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Acamprosate—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Acamprosate—Agitation—Prednisone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Acamprosate—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Acamprosate—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Acamprosate—Tachycardia—Betamethasone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Acamprosate—Tachycardia—Dexamethasone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Acamprosate—Angioedema—Prednisone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Acamprosate—Dyspepsia—Triamcinolone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Acamprosate—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Acamprosate—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Acamprosate—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Acamprosate—Malaise—Prednisone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Acamprosate—Vertigo—Prednisone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Acamprosate—Syncope—Prednisone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Acamprosate—Tinnitus—Methotrexate—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Acamprosate—Anorexia—Dexamethasone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Acamprosate—Anorexia—Betamethasone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Acamprosate—Urticaria—Prednisolone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Acamprosate—Pain—Triamcinolone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Acamprosate—Loss of consciousness—Prednisone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Acamprosate—Hypotension—Betamethasone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Acamprosate—Hypotension—Dexamethasone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Acamprosate—Immune system disorder—Methotrexate—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Acamprosate—Convulsion—Prednisone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Acamprosate—Hypertension—Prednisone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Acamprosate—Chills—Methotrexate—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Acamprosate—Myalgia—Prednisone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Acamprosate—Arthralgia—Prednisone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Acamprosate—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Acamprosate—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Acamprosate—Anxiety—Prednisone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Acamprosate—Alopecia—Methotrexate—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Acamprosate—Insomnia—Betamethasone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Acamprosate—Insomnia—Dexamethasone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Acamprosate—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Acamprosate—Paraesthesia—Betamethasone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Acamprosate—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Acamprosate—Discomfort—Prednisone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Acamprosate—Mental disorder—Methotrexate—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Acamprosate—Malnutrition—Methotrexate—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Acamprosate—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000999	0.000999	CcSEcCtD
Acamprosate—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000996	0.000996	CcSEcCtD
Acamprosate—Dyspepsia—Betamethasone—psoriatic arthritis	0.000996	0.000996	CcSEcCtD
Acamprosate—Urticaria—Triamcinolone—psoriatic arthritis	0.00099	0.00099	CcSEcCtD
Acamprosate—Urticaria—Methylprednisolone—psoriatic arthritis	0.000988	0.000988	CcSEcCtD
Acamprosate—Dysgeusia—Methotrexate—psoriatic arthritis	0.000988	0.000988	CcSEcCtD
Acamprosate—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000986	0.000986	CcSEcCtD
Acamprosate—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000985	0.000985	CcSEcCtD
Acamprosate—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000983	0.000983	CcSEcCtD
Acamprosate—Decreased appetite—Betamethasone—psoriatic arthritis	0.000983	0.000983	CcSEcCtD
Acamprosate—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000983	0.000983	CcSEcCtD
Acamprosate—Infection—Prednisone—psoriatic arthritis	0.000979	0.000979	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000977	0.000977	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000977	0.000977	CcSEcCtD
Acamprosate—Back pain—Methotrexate—psoriatic arthritis	0.000976	0.000976	CcSEcCtD
Acamprosate—Shock—Prednisone—psoriatic arthritis	0.000969	0.000969	CcSEcCtD
Acamprosate—Pain—Dexamethasone—psoriatic arthritis	0.000967	0.000967	CcSEcCtD
Acamprosate—Pain—Betamethasone—psoriatic arthritis	0.000967	0.000967	CcSEcCtD
Acamprosate—Tachycardia—Prednisone—psoriatic arthritis	0.000961	0.000961	CcSEcCtD
Acamprosate—Skin disorder—Prednisone—psoriatic arthritis	0.000957	0.000957	CcSEcCtD
Acamprosate—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000952	0.000952	CcSEcCtD
Acamprosate—Anorexia—Prednisone—psoriatic arthritis	0.000939	0.000939	CcSEcCtD
Acamprosate—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000936	0.000936	CcSEcCtD
Acamprosate—Anaemia—Methotrexate—psoriatic arthritis	0.000932	0.000932	CcSEcCtD
Acamprosate—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000932	0.000932	CcSEcCtD
Acamprosate—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000932	0.000932	CcSEcCtD
Acamprosate—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000925	0.000925	CcSEcCtD
Acamprosate—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000925	0.000925	CcSEcCtD
Acamprosate—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000919	0.000919	CcSEcCtD
Acamprosate—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000916	0.000916	CcSEcCtD
Acamprosate—Malaise—Methotrexate—psoriatic arthritis	0.00091	0.00091	CcSEcCtD
Acamprosate—Vertigo—Methotrexate—psoriatic arthritis	0.000906	0.000906	CcSEcCtD
Acamprosate—Leukopenia—Methotrexate—psoriatic arthritis	0.000903	0.000903	CcSEcCtD
Acamprosate—Urticaria—Dexamethasone—psoriatic arthritis	0.000899	0.000899	CcSEcCtD
Acamprosate—Urticaria—Betamethasone—psoriatic arthritis	0.000899	0.000899	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000898	0.000898	CcSEcCtD
Acamprosate—Dizziness—Prednisolone—psoriatic arthritis	0.000896	0.000896	CcSEcCtD
Acamprosate—Asthenia—Triamcinolone—psoriatic arthritis	0.000894	0.000894	CcSEcCtD
Acamprosate—Body temperature increased—Betamethasone—psoriatic arthritis	0.000894	0.000894	CcSEcCtD
Acamprosate—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000894	0.000894	CcSEcCtD
Acamprosate—Abdominal pain—Betamethasone—psoriatic arthritis	0.000894	0.000894	CcSEcCtD
Acamprosate—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000894	0.000894	CcSEcCtD
Acamprosate—Asthenia—Methylprednisolone—psoriatic arthritis	0.000892	0.000892	CcSEcCtD
Acamprosate—Insomnia—Prednisone—psoriatic arthritis	0.000891	0.000891	CcSEcCtD
Acamprosate—Paraesthesia—Prednisone—psoriatic arthritis	0.000885	0.000885	CcSEcCtD
Acamprosate—Pruritus—Triamcinolone—psoriatic arthritis	0.000882	0.000882	CcSEcCtD
Acamprosate—Cough—Methotrexate—psoriatic arthritis	0.00088	0.00088	CcSEcCtD
Acamprosate—Pruritus—Methylprednisolone—psoriatic arthritis	0.00088	0.00088	CcSEcCtD
Acamprosate—Convulsion—Methotrexate—psoriatic arthritis	0.000874	0.000874	CcSEcCtD
Acamprosate—Dyspepsia—Prednisone—psoriatic arthritis	0.000867	0.000867	CcSEcCtD
Acamprosate—Chest pain—Methotrexate—psoriatic arthritis	0.000859	0.000859	CcSEcCtD
Acamprosate—Myalgia—Methotrexate—psoriatic arthritis	0.000859	0.000859	CcSEcCtD
Acamprosate—Arthralgia—Methotrexate—psoriatic arthritis	0.000859	0.000859	CcSEcCtD
Acamprosate—Decreased appetite—Prednisone—psoriatic arthritis	0.000856	0.000856	CcSEcCtD
Acamprosate—Rash—Prednisolone—psoriatic arthritis	0.000855	0.000855	CcSEcCtD
Acamprosate—Dermatitis—Prednisolone—psoriatic arthritis	0.000854	0.000854	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000853	0.000853	CcSEcCtD
Acamprosate—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000851	0.000851	CcSEcCtD
Acamprosate—Headache—Prednisolone—psoriatic arthritis	0.000849	0.000849	CcSEcCtD
Acamprosate—Discomfort—Methotrexate—psoriatic arthritis	0.000849	0.000849	CcSEcCtD
Acamprosate—Constipation—Prednisone—psoriatic arthritis	0.000842	0.000842	CcSEcCtD
Acamprosate—Confusional state—Methotrexate—psoriatic arthritis	0.00083	0.00083	CcSEcCtD
Acamprosate—Dizziness—Triamcinolone—psoriatic arthritis	0.000824	0.000824	CcSEcCtD
Acamprosate—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000823	0.000823	CcSEcCtD
Acamprosate—Dizziness—Methylprednisolone—psoriatic arthritis	0.000823	0.000823	CcSEcCtD
Acamprosate—Infection—Methotrexate—psoriatic arthritis	0.000818	0.000818	CcSEcCtD
Acamprosate—Feeling abnormal—Prednisone—psoriatic arthritis	0.000812	0.000812	CcSEcCtD
Acamprosate—Asthenia—Dexamethasone—psoriatic arthritis	0.000812	0.000812	CcSEcCtD
Acamprosate—Asthenia—Betamethasone—psoriatic arthritis	0.000812	0.000812	CcSEcCtD
Acamprosate—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000806	0.000806	CcSEcCtD
Acamprosate—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000806	0.000806	CcSEcCtD
Acamprosate—Nausea—Prednisolone—psoriatic arthritis	0.000805	0.000805	CcSEcCtD
Acamprosate—Pruritus—Dexamethasone—psoriatic arthritis	0.0008	0.0008	CcSEcCtD
Acamprosate—Pruritus—Betamethasone—psoriatic arthritis	0.0008	0.0008	CcSEcCtD
Acamprosate—Skin disorder—Methotrexate—psoriatic arthritis	0.0008	0.0008	CcSEcCtD
Acamprosate—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000796	0.000796	CcSEcCtD
Acamprosate—Vomiting—Triamcinolone—psoriatic arthritis	0.000793	0.000793	CcSEcCtD
Acamprosate—Vomiting—Methylprednisolone—psoriatic arthritis	0.000791	0.000791	CcSEcCtD
Acamprosate—Rash—Triamcinolone—psoriatic arthritis	0.000786	0.000786	CcSEcCtD
Acamprosate—Dermatitis—Triamcinolone—psoriatic arthritis	0.000785	0.000785	CcSEcCtD
Acamprosate—Anorexia—Methotrexate—psoriatic arthritis	0.000785	0.000785	CcSEcCtD
Acamprosate—Rash—Methylprednisolone—psoriatic arthritis	0.000784	0.000784	CcSEcCtD
Acamprosate—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000784	0.000784	CcSEcCtD
Acamprosate—Urticaria—Prednisone—psoriatic arthritis	0.000783	0.000783	CcSEcCtD
Acamprosate—Headache—Triamcinolone—psoriatic arthritis	0.000781	0.000781	CcSEcCtD
Acamprosate—Headache—Methylprednisolone—psoriatic arthritis	0.000779	0.000779	CcSEcCtD
Acamprosate—Abdominal pain—Prednisone—psoriatic arthritis	0.000779	0.000779	CcSEcCtD
Acamprosate—Body temperature increased—Prednisone—psoriatic arthritis	0.000779	0.000779	CcSEcCtD
Acamprosate—Diarrhoea—Betamethasone—psoriatic arthritis	0.000774	0.000774	CcSEcCtD
Acamprosate—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000774	0.000774	CcSEcCtD
Acamprosate—Hypotension—Methotrexate—psoriatic arthritis	0.000769	0.000769	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00075	0.00075	CcSEcCtD
Acamprosate—Dizziness—Dexamethasone—psoriatic arthritis	0.000748	0.000748	CcSEcCtD
Acamprosate—Dizziness—Betamethasone—psoriatic arthritis	0.000748	0.000748	CcSEcCtD
Acamprosate—Insomnia—Methotrexate—psoriatic arthritis	0.000745	0.000745	CcSEcCtD
Acamprosate—Nausea—Triamcinolone—psoriatic arthritis	0.000741	0.000741	CcSEcCtD
Acamprosate—Paraesthesia—Methotrexate—psoriatic arthritis	0.000739	0.000739	CcSEcCtD
Acamprosate—Nausea—Methylprednisolone—psoriatic arthritis	0.000739	0.000739	CcSEcCtD
Acamprosate—Dyspnoea—Methotrexate—psoriatic arthritis	0.000734	0.000734	CcSEcCtD
Acamprosate—Somnolence—Methotrexate—psoriatic arthritis	0.000732	0.000732	CcSEcCtD
Acamprosate—Hypersensitivity—Prednisone—psoriatic arthritis	0.000726	0.000726	CcSEcCtD
Acamprosate—Dyspepsia—Methotrexate—psoriatic arthritis	0.000725	0.000725	CcSEcCtD
Acamprosate—Vomiting—Betamethasone—psoriatic arthritis	0.000719	0.000719	CcSEcCtD
Acamprosate—Vomiting—Dexamethasone—psoriatic arthritis	0.000719	0.000719	CcSEcCtD
Acamprosate—Decreased appetite—Methotrexate—psoriatic arthritis	0.000716	0.000716	CcSEcCtD
Acamprosate—Rash—Betamethasone—psoriatic arthritis	0.000713	0.000713	CcSEcCtD
Acamprosate—Rash—Dexamethasone—psoriatic arthritis	0.000713	0.000713	CcSEcCtD
Acamprosate—Dermatitis—Betamethasone—psoriatic arthritis	0.000713	0.000713	CcSEcCtD
Acamprosate—Dermatitis—Dexamethasone—psoriatic arthritis	0.000713	0.000713	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000711	0.000711	CcSEcCtD
Acamprosate—Headache—Dexamethasone—psoriatic arthritis	0.000709	0.000709	CcSEcCtD
Acamprosate—Headache—Betamethasone—psoriatic arthritis	0.000709	0.000709	CcSEcCtD
Acamprosate—Asthenia—Prednisone—psoriatic arthritis	0.000707	0.000707	CcSEcCtD
Acamprosate—Pain—Methotrexate—psoriatic arthritis	0.000704	0.000704	CcSEcCtD
Acamprosate—Pruritus—Prednisone—psoriatic arthritis	0.000697	0.000697	CcSEcCtD
Acamprosate—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000678	0.000678	CcSEcCtD
Acamprosate—Diarrhoea—Prednisone—psoriatic arthritis	0.000674	0.000674	CcSEcCtD
Acamprosate—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000673	0.000673	CcSEcCtD
Acamprosate—Nausea—Betamethasone—psoriatic arthritis	0.000672	0.000672	CcSEcCtD
Acamprosate—Nausea—Dexamethasone—psoriatic arthritis	0.000672	0.000672	CcSEcCtD
Acamprosate—Urticaria—Methotrexate—psoriatic arthritis	0.000654	0.000654	CcSEcCtD
Acamprosate—Dizziness—Prednisone—psoriatic arthritis	0.000651	0.000651	CcSEcCtD
Acamprosate—Abdominal pain—Methotrexate—psoriatic arthritis	0.000651	0.000651	CcSEcCtD
Acamprosate—Body temperature increased—Methotrexate—psoriatic arthritis	0.000651	0.000651	CcSEcCtD
Acamprosate—Vomiting—Prednisone—psoriatic arthritis	0.000626	0.000626	CcSEcCtD
Acamprosate—Rash—Prednisone—psoriatic arthritis	0.000621	0.000621	CcSEcCtD
Acamprosate—Dermatitis—Prednisone—psoriatic arthritis	0.000621	0.000621	CcSEcCtD
Acamprosate—Headache—Prednisone—psoriatic arthritis	0.000617	0.000617	CcSEcCtD
Acamprosate—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000607	0.000607	CcSEcCtD
Acamprosate—Asthenia—Methotrexate—psoriatic arthritis	0.000591	0.000591	CcSEcCtD
Acamprosate—Nausea—Prednisone—psoriatic arthritis	0.000585	0.000585	CcSEcCtD
Acamprosate—Pruritus—Methotrexate—psoriatic arthritis	0.000582	0.000582	CcSEcCtD
Acamprosate—Diarrhoea—Methotrexate—psoriatic arthritis	0.000563	0.000563	CcSEcCtD
Acamprosate—Dizziness—Methotrexate—psoriatic arthritis	0.000544	0.000544	CcSEcCtD
Acamprosate—Vomiting—Methotrexate—psoriatic arthritis	0.000523	0.000523	CcSEcCtD
Acamprosate—Rash—Methotrexate—psoriatic arthritis	0.000519	0.000519	CcSEcCtD
Acamprosate—Dermatitis—Methotrexate—psoriatic arthritis	0.000519	0.000519	CcSEcCtD
Acamprosate—Headache—Methotrexate—psoriatic arthritis	0.000516	0.000516	CcSEcCtD
Acamprosate—Nausea—Methotrexate—psoriatic arthritis	0.000489	0.000489	CcSEcCtD
